Active Agent in ‘Magic Mushrooms’ May Be Therapeutic

A new imaging study supports evidence that psilocybin, the active ingredient in ‘magic mushrooms,’ may have therapeutic effects for conditions such as depression, anxiety, and cluster headache. Medscape Medical News

Aspirin may reduce depressive symptoms in survivors of ACS

Aspirin has been commonly used for prevention of cardiovascular disease. Depression has been found to be an important prognostic factor after heart attacks. But what is their relationship? This is addressed by a study published in the 5th 2011 issue of Psychotherapy and Psychosomatics.

Mephedrone Decreases Memory, Increases Depression, Craving

In a new study, mephedrone users experienced impaired working memory and increased depression scores and reported a longing for a “new legal high.” Medscape Medical News

Antidepressants Tied To Higher Risk Of Falls In Nursing Home Residents With Dementia

Compared to similar people who don’t take them, nursing home residents with dementia who take average doses of a class of drugs used to treat depression are three times more likely to have an injurious fall. These are the findings of a new study from The Netherlands published online in the British [...]

Can Strong Religious Beliefs Reduce Recurrent Depression Risk?

A strong belief in religion or spirituality may provide a protective effect against the recurrence of depression, especially in offspring of parents with a history of depression. Medscape Medical News

Combine Diabetes, Depression Care for Best Results (CME/CE)

(MedPage Today) — Tackling depression and diabetes together in primary care is more likely to get both under control than approaching them separately, researchers found.

Complex Patients Benefit from Team Approach (CME/CE)

(MedPage Today) — A team-based approach helps improve control of diabetes, coronary heart disease, and depression in the primary care setting by modifying both patient and physician behaviors, researchers found.

Positive results from Alkermes ALKS 5461 phase 1/2 study on MDD

Alkermes plc today announced positive topline results from a phase 1/2 study of ALKS 5461, a novel drug compound for major depressive disorder (MDD) in patients who have an inadequate response to standard therapies for clinical depression.

Truancy Signals Depression in Kids (CME/CE)

(MedPage Today) — Missing school appears to be both a cause and a symptom of depression, researchers have found.

Mothers With Jobs Report Fewer Symptoms Of Depression, Better Overall Health

Mothers with jobs tend to be healthier and happier than moms who stay at home during their children’s infancy and pre-school years, according to a new study published by the American Psychological Association…